{"id":34429,"date":"2024-11-26T16:16:07","date_gmt":"2024-11-26T16:16:07","guid":{"rendered":"https:\/\/bnssghealthiertogether.org.uk\/?page_id=34429"},"modified":"2025-01-15T22:47:12","modified_gmt":"2025-01-15T22:47:12","slug":"evidence-to-support-the-joint-formulary-group-jfg-uses-of-melatonin","status":"publish","type":"page","link":"https:\/\/bnssghealthiertogether.org.uk\/sq\/integrated-care-board\/research-and-evidence\/impact-case-studies\/evidence-to-support-the-joint-formulary-group-jfg-uses-of-melatonin\/","title":{"rendered":"Prova n\u00eb mb\u00ebshtetje t\u00eb Grupit t\u00eb P\u00ebrbashk\u00ebt t\u00eb Formularit (JFG) - P\u00ebrdorimet e Melatonin\u00ebs"},"content":{"rendered":"<div class=\"assembler_default-group assembler_module_group assembler_default-group_1 assembler_module_group_1\"><div class=\"assembler_module_area assembler_module_area_1\"><div class=\"assembler_text-module assembler_module assembler_text-module_1 assembler_module_1  transparent\"><a tabindex=\"-1\" title=\"Seksioni me titull module-1\" id=\"module-1\" href=\"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/34429\/#module-1\" class=\"anchor\"><span class=\"hidden\">Seksioni me titull module-1<\/span><\/a><!-- Template found for text-module - Template: template-text - Matched: _only --><section class=\"w-full mx-auto max-w-content pt-12 sm:pt-24 pb-12 sm:pb-24\">\r\n  <div class=\"entry-content w-full !px-0 max-w-small\">\r\n        <h1>Prova n\u00eb mb\u00ebshtetje t\u00eb Grupit t\u00eb P\u00ebrbashk\u00ebt t\u00eb Formularit (JFG) - P\u00ebrdorimet e Melatonin\u00ebs<\/h1>\n<p>Ekipi i Optimizimit t\u00eb Barnave n\u00eb NHS Bristol, North Somerset dhe South Gloucestershire ICB koordinon Grupin e P\u00ebrbashk\u00ebt t\u00eb Formularit (JFG). JFG p\u00ebrfshin p\u00ebrfaq\u00ebsues nga kujdesi par\u00ebsor dhe sekondar q\u00eb mbulojn\u00eb t\u00eb gjitha recetat n\u00eb t\u00eb gjith\u00eb Bristolin, North Somerset dhe South Gloucestershire.<\/p>\n<p>Formulari i P\u00ebrbashk\u00ebt p\u00ebrcakton k\u00ebrkesat p\u00ebr p\u00ebrshkrimin e ila\u00e7eve me kosto efektive n\u00eb vend. \u00c7do ila\u00e7 q\u00eb nuk \u00ebsht\u00eb i listuar n\u00eb Formular konsiderohet si Jo-Formular dhe nuk duhet t\u00eb p\u00ebrshkruhet rregullisht. Ju lutemi shihni <a href=\"https:\/\/remedy.bnssg.icb.nhs.uk\/\" rel=\"noopener\">Uebfaqja e Formularit t\u00eb P\u00ebrbashk\u00ebt t\u00eb Bristolit, Somersetit Verior dhe Gloucestershirit Jugor<\/a> p\u00ebr m\u00eb shum\u00eb informacion.<\/p>\n<p>Ekipit t\u00eb Efektivitetit Klinik t\u00eb ICB iu k\u00ebrkua t\u00eb mb\u00ebshteste JFG-n\u00eb n\u00eb p\u00ebrgjigje t\u00eb aplikimeve t\u00eb b\u00ebra p\u00ebr tre indikacione t\u00eb ndryshme p\u00ebr melatonin\u00ebn. Aplikimet ishin p\u00ebr p\u00ebrdorim si m\u00eb posht\u00eb:<\/p>\n<ol>\n<li>Melatonin\u00eb p\u00ebr trajtimin e \u00e7rregullimeve t\u00eb gjumit tek pacient\u00ebt e rritur me demenc\u00eb pasi t\u00eb p\u00ebrjashtohen shkaqet fizike\/psikologjike dhe masat e higjien\u00ebs s\u00eb gjumit kan\u00eb d\u00ebshtuar.<\/li>\n<li>Melatonin\u00eb p\u00ebr t\u00eb ndihmuar n\u00eb fillimin e gjumit tek f\u00ebmij\u00ebt n\u00eb Nj\u00ebsin\u00eb e Kujdesit Intensiv Pediatrik (PICU) ose Nj\u00ebsin\u00eb Pediatrike me Var\u00ebsi t\u00eb Lart\u00eb (PHDU) kur masat e higjien\u00ebs s\u00eb gjumit kan\u00eb d\u00ebshtuar.<\/li>\n<li>Melatonina p\u00ebr trajtimin e \u00e7rregullimeve t\u00eb gjumit tek pacient\u00ebt me \u00c7rregullim t\u00eb Hiperaktivitetit dhe Munges\u00eb V\u00ebmendjeje (ADHD), V\u00ebshtir\u00ebsi n\u00eb t\u00eb Nx\u00ebn\u00eb (LD) dhe\/ose \u00c7rregullim t\u00eb Spektrit Autik (ASD) pasi t\u00eb p\u00ebrjashtohen shkaqet fizike\/psikologjike dhe masat e higjien\u00ebs s\u00eb gjumit kan\u00eb d\u00ebshtuar.<\/li>\n<\/ol>\n<h2><strong>Kontributi i Ekipit t\u00eb Efektivitetit Klinik<\/strong><\/h2>\n<p>Ekipi i Efektivitetit Klinik (CE) i ICB nd\u00ebrmori tre shqyrtime t\u00eb provave, nj\u00eb p\u00ebr secilin prej p\u00ebrdorimeve t\u00eb propozuara t\u00eb melatonin\u00ebs t\u00eb listuara m\u00eb sip\u00ebr, p\u00ebr t\u00eb mb\u00ebshtetur vendimmarrjen e JFG-s\u00eb.<\/p>\n<p>N\u00eb k\u00ebto shqyrtime t\u00eb provave, p\u00ebr aq sa ishte e mundur, u trajtuan pikat e m\u00ebposhtme p\u00ebr t\u00eb ndihmuar diskutimin n\u00eb JFG:<\/p>\n<ul>\n<li>Cil\u00ebsia dhe fuqia e provave<\/li>\n<li>Siguria e pacientit<\/li>\n<li>Efikasiteti dhe efektiviteti klinik<\/li>\n<li>Efektiviteti i kostos dhe ndikimi n\u00eb burime.<\/li>\n<\/ul>\n<h2><strong>Ndikimi i &#039;Melatonin\u00ebs p\u00ebr rezultatet e gjumit n\u00eb demenc\u00eb&#039;\u2018<\/strong><\/h2>\n<p>Rishikimi i provave tregoi nj\u00eb munges\u00eb t\u00eb provave k\u00ebrkimore me cil\u00ebsi t\u00eb mir\u00eb q\u00eb shqyrtojn\u00eb p\u00ebrdorimin e melatonin\u00ebs p\u00ebr rezultatet e gjumit n\u00eb demenc\u00eb. Provat e disponueshme u p\u00ebrqendruan kryesisht n\u00eb s\u00ebmundjen e Alzheimerit sesa n\u00eb llojet e tjera t\u00eb demenc\u00ebs.<\/p>\n<p>Rezultati i diskutimit t\u00eb JFG-s\u00eb rreth k\u00ebtij p\u00ebrdorimi t\u00eb melatonin\u00ebs ishte se, bazuar n\u00eb munges\u00eb provash, ai <strong><em>nuk do t\u00eb ishte<\/em><\/strong> shtuar n\u00eb formular n\u00eb k\u00ebt\u00eb koh\u00eb. Megjithat\u00eb, duke pasur parasysh munges\u00ebn e studimeve q\u00eb shqyrtojn\u00eb k\u00ebt\u00eb indikacion, por provat e konsiderueshme anekdotike t\u00eb p\u00ebrfitimit, aty ku ishte p\u00ebrdorur &#039;jasht\u00eb formularit&#039; n\u00eb Bristol, Somerset Verior dhe Gloucestershire Jugor, u porosit nj\u00eb studim lokal p\u00ebr t\u00eb zhvilluar nj\u00eb baz\u00eb provash p\u00ebr zon\u00ebn.<\/p>\n<p>Rezultatet e k\u00ebtij studimi do t\u00eb ndihmojn\u00eb n\u00eb vendimmarrjen p\u00ebr aplikimet e ardhshme t\u00eb JFG p\u00ebr p\u00ebrdorimin e melatonin\u00ebs n\u00eb trajtimin e \u00e7rregullimeve t\u00eb gjumit tek pacient\u00ebt e rritur me demenc\u00eb.<\/p>\n<p>Meqen\u00ebse nj\u00eb vendim u arrit dhe u miratua menj\u00ebher\u00eb pas takimit t\u00eb JFG-s\u00eb, ky shqyrtim i provave u konsiderua i p\u00ebrshtatsh\u00ebm p\u00ebr t&#039;u ndar\u00eb n\u00eb <a href=\"https:\/\/future.nhs.uk\/system\/login?nextURL=%2Fconnect%2Eti%2FWEAHSNevidence%2FgroupHome\" rel=\"noopener\">Depozita e D\u00ebshmive WEAHSN<\/a>.<\/p>\n<h2><strong>Ndikimi i &#039;Melatonin\u00ebs p\u00ebr rezultatet e gjumit n\u00eb PICU\/PHDU&#039;\u2018<\/strong><\/h2>\n<p>Rishikimi i provave tregoi nj\u00eb munges\u00eb t\u00eb dukshme provash mbi efektivitetin e p\u00ebrdorimit t\u00eb melatonin\u00ebs n\u00eb mjediset e PICU-s\u00eb dhe PHDU-s\u00eb. Megjithat\u00eb, kishte prova q\u00eb melatonina ka nj\u00eb profil t\u00eb mir\u00eb sigurie n\u00eb popullatat pediatrike dhe mund t\u00eb jet\u00eb e dobishme p\u00ebr rezultatet e gjumit tek f\u00ebmij\u00ebt n\u00eb nj\u00eb shkall\u00eb m\u00eb t\u00eb gjer\u00eb.<\/p>\n<p>P\u00ebr m\u00eb tep\u00ebr, kishte prova se recetat \u2018jasht\u00eb formularit\u2019 p\u00ebr melatonin\u00ebn n\u00eb PICU\/PHDU po rriteshin n\u00eb nivel nd\u00ebrkomb\u00ebtar.<\/p>\n<p>Rezultati i diskutimit JFG n\u00eb lidhje me k\u00ebt\u00eb p\u00ebrdorim t\u00eb melatonin\u00ebs ishte se duke pasur parasysh profilin e siguris\u00eb s\u00eb p\u00ebrdorimit t\u00eb melatonin\u00ebs tek pediatrit dhe koh\u00ebzgjatjen afatshkurt\u00ebr t\u00eb administrimit t\u00eb melatonin\u00ebs (dometh\u00ebn\u00eb, vet\u00ebm nd\u00ebrsa f\u00ebmija \u00ebsht\u00eb n\u00eb PICU\/PHDU), ai <strong><em>do t\u00eb ishte<\/em><\/strong> shtuar n\u00eb formular. Ekziston pritja q\u00eb p\u00ebrdorimi &#039;n\u00eb formular&#039; do t\u00eb mund\u00ebsoj\u00eb nj\u00eb mbledhje m\u00eb t\u00eb mir\u00eb t\u00eb t\u00eb dh\u00ebnave lokale mbi p\u00ebrdorimin e melatonin\u00ebs p\u00ebr k\u00ebt\u00eb q\u00ebllim.<\/p>\n<p>Meqen\u00ebse nj\u00eb vendim u arrit dhe u miratua menj\u00ebher\u00eb pas takimit t\u00eb JFG-s\u00eb, ky shqyrtim i provave u konsiderua i p\u00ebrshtatsh\u00ebm p\u00ebr t&#039;u ndar\u00eb n\u00eb <a href=\"https:\/\/future.nhs.uk\/system\/login?nextURL=%2Fconnect%2Eti%2FWEAHSNevidence%2FgroupHome\" rel=\"noopener\">Depozita e D\u00ebshmive WEAHSN<\/a>.<\/p>\n<h2><strong>Ndikimi i &#039;P\u00ebrdorimit t\u00eb melatonin\u00ebs p\u00ebr rezultatet e gjumit n\u00eb ADHD\/LD\/ASD&#039;\u2018<\/strong><\/h2>\n<p>Rishikimi i provave tregoi nj\u00eb v\u00ebllim t\u00eb konsideruesh\u00ebm provash klinike q\u00eb shqyrtojn\u00eb p\u00ebrdorimin e melatonin\u00ebs p\u00ebr rezultatet e gjumit tek pacient\u00ebt me ADHD, LD dhe\/ose ASD. Megjithat\u00eb, pavar\u00ebsisht k\u00ebsaj, shumica e provave ishin t\u00eb kufizuara nga cil\u00ebsia e ndryshueshme p\u00ebr shkak t\u00eb heterogjenitetit metodologjik, popullatave t\u00eb vler\u00ebsuara dhe rrezikut t\u00eb paragjykimit.<\/p>\n<p>Rishikimi tregoi se mund t\u00eb ket\u00eb m\u00eb shum\u00eb prova p\u00ebr p\u00ebrdorimin e melatonin\u00ebs p\u00ebr LD dhe ASD, n\u00eb vend t\u00eb ADHD.<\/p>\n<p>Rezultati i diskutimit t\u00eb JFG-s\u00eb rreth k\u00ebtij p\u00ebrdorimi t\u00eb melatonin\u00ebs ishte se ai <strong><em>nuk do t\u00eb ishte<\/em><\/strong> shtuar n\u00eb formularin p\u00ebr ADHD, por <strong><em>mund t\u00eb jet\u00eb<\/em><\/strong> shtuar p\u00ebr LD dhe ASD.<\/p>\n<p>K\u00ebrkohet pun\u00eb e m\u00ebtejshme p\u00ebrpara se t\u00eb merret nj\u00eb vendim p\u00ebr b\u00ebrjen e k\u00ebtyre ndryshimeve p\u00ebr shkak t\u00eb kostove shtes\u00eb financiare q\u00eb do t\u00eb shkaktoheshin nga sistemi.<\/p>\n<h2><strong>Reflektime shtes\u00eb mbi ndikimin<\/strong><\/h2>\n<p>Kur u pyet\u00ebn p\u00ebr reflektimet e tyre mbi ndikimin e mb\u00ebshtetjes s\u00eb ekipit t\u00eb CE-s\u00eb n\u00eb procesin e vendimmarrjes s\u00eb JFG-s\u00eb, an\u00ebtar\u00ebt e ekipit t\u00eb Optimizimit t\u00eb Barnave treguan se ishte shum\u00eb e dobishme t&#039;ia jepnin me kontrat\u00eb shqyrtimin e provave ekipit t\u00eb CE-s\u00eb p\u00ebr disa arsye:<\/p>\n<ol>\n<li>Pavar\u00ebsia e ekipit CE nga procesi i vendimmarrjes s\u00eb JFG u konsiderua se i kishte shtuar rigorozitet procesit t\u00eb tij t\u00eb siguris\u00eb duke ofruar shqyrtime t\u00eb paanshme t\u00eb provave.<\/li>\n<li>Ekipi i Optimizimit t\u00eb Mjek\u00ebsis\u00eb nuk kishte as kapacitetin dhe as aft\u00ebsit\u00eb e nevojshme p\u00ebr t\u00eb kryer shqyrtime t\u00eb provave, me nj\u00eb nivel t\u00eb mjaftuesh\u00ebm thell\u00ebsie dhe vler\u00ebsimi kritik, p\u00ebr t\u00eb mund\u00ebsuar vendime objektive n\u00eb lidhje me shtimin e melatonin\u00ebs n\u00eb formular p\u00ebr indikacionet e listuara m\u00eb par\u00eb.<\/li>\n<li>Procesi i aplikimit mund t\u00eb jet\u00eb emocional, me pal\u00eb t\u00eb interesuara t\u00eb apasionuara q\u00eb ndajn\u00eb prova anekdotike se pse besojn\u00eb se k\u00ebrkesa e tyre p\u00ebr formular duhet t\u00eb jet\u00eb e suksesshme. Megjithat\u00eb, shqyrtimet e provave pa interes i mund\u00ebsuan JFG-s\u00eb t\u00eb poziciononte dhe peshonte format e ndryshme t\u00eb provave n\u00eb nj\u00eb m\u00ebnyr\u00eb m\u00eb t\u00eb paanshme.<\/li>\n<\/ol>\n<p>Q\u00eb kur jan\u00eb kryer k\u00ebto rishikime, ekipi i CE-s\u00eb ka mb\u00ebshtetur ekipin e Optimizimit t\u00eb Barnave me m\u00eb shum\u00eb rishikime t\u00eb provave p\u00ebr t\u00eb mb\u00ebshtetur aplikimet e reja p\u00ebr shtesa n\u00eb formular.<\/p>\n  <\/div>\r\n  <\/section><\/div><!-- .assembler_text-module.assembler_module.assembler_text-module_1.assembler_module_1..transparent --><\/div><!-- .assembler_module_area.assembler_module_area_1 --><\/div><!-- .assembler_default-group.assembler_module_group.assembler_default-group_1.assembler_module_group_1  -->","protected":false},"excerpt":{"rendered":"<p>Section titled module-1 Evidence to support the Joint Formulary Group (JFG)- Uses of Melatonin The Medicines Optimisation team at NHS Bristol, North Somerset, and South Gloucestershire ICB coordinate the Joint Formulary Group (JFG).\u00a0 The JFG includes representatives from primary and secondary care covering all prescribing across Bristol, North Somerset and South Gloucestershire. The Joint Formulary [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":32870,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"tags":[],"class_list":["post-34429","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/34429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/comments?post=34429"}],"version-history":[{"count":3,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/34429\/revisions"}],"predecessor-version":[{"id":36079,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/34429\/revisions\/36079"}],"up":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/pages\/32870"}],"wp:attachment":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/media?parent=34429"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/sq\/wp-json\/wp\/v2\/tags?post=34429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}